D68.01
Von Willebrand disease, type 1
Clinical Classification Guidelines
Inclusion Terms
- Partial quantitative deficiency of von Willebrand factor
- Type 1C von Willebrand disease
Medical Intelligence & Overview
Von Willebrand Disease (VWD) is a common hereditary bleeding disorder caused by a deficiency or dysfunction of a protein called von Willebrand factor (VWF). The Type 1 variant, identified under ICD-10 code D68.01, is characterized by a partial quantitative deficiency of VWF, leading to increased bleeding tendencies. This condition is often inherited and can vary in severity from mild to more significant bleeding issues. Recognizing the symptoms and understanding the causes and management options can help individuals affected by this disorder better navigate their health.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents, following an autosomal dominant pattern Partial deficiency of von Willebrand factor due to decreased production Possible family history of unexplained bleeding episodes Rarely, acquired forms caused by other medical conditions or medications
Key Symptoms: Frequent nosebleeds that are difficult to control Easy bruising on the skin after minor injuries Prolonged bleeding from cuts or wounds Heavy or prolonged menstrual bleeding in women Bleeding gums after dental procedures Blood in urine or stool in severe cases Bleeding after surgery or dental work
Diagnostic & Treatment
Diagnosis Path: Diagnosing Type 1 VWD involves a combination of blood tests to measure levels and function of von Willebrand factor. Common diagnostic steps include: - Complete blood count (CBC) to assess overall blood health - Von Willebrand factor antigen test to determine VWF levels - Ristocetin co-factor activity test to evaluate the function of VWF - Additional specialized tests to distinguish between different types of VWD A thorough medical history and family history are also essential in confirming the diagnosis.
Treatment Protocols: Management of Type 1 Von Willebrand Disease focuses on controlling bleeding episodes and preventing future issues. Treatment options include: - Desmopressin (DDAVP): A medication that releases stored VWF and factor VIII into the bloodstream, effective for many with Type 1 VWD - Humate-P or other VWF concentrates: Used in cases where desmopressin is ineffective or contraindicated, especially during surgery or severe bleeding - Antifibrinolytic medications: Such as tranexamic acid or epsilon-aminocaproic acid, to help prevent breakdown of blood clots - Avoidance of medications that can worsen bleeding, such as aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) - Regular follow-up with healthcare providers to monitor VWF levels and bleeding tendencies
Clinical Advice & FAQs
Billing Guidance
Is D68.01 a billable ICD-10 code?
Yes, D68.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D68.01?
Clinical documentation must specify the nature of Von Willebrand disease, type 1 and any associated comorbidities for accurate reporting.
Cite this Clinical Reference